We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antimicrobial resistance in India.
- Authors
Swetha, N. B.; Shivani, M.; Gopalakrishnan, S.
- Abstract
Antimicrobial resistance (AMR) or medicate obstruction occurs when microorganisms, parasites, and infections never again react to a medication that recently treated them viably. AMR leads to the accompanying issues such as few diseases being more difficult to control and remain for longer duration inside the body, longer medical clinic stays, and expanding the monetary and social expenses of contamination. A characteristic and gained system of antimicrobial obstruction has been distinguished in numerous bacterial strains that are of high clinical significance. This has genuinely endangered the utilization of antimicrobials and has caused the spread of microorganisms that remain unharmed to the standard first decision or firstline drugs. Thus, the treatment for a wide range of diseases like tuberculosis has been adversely affected due to this increased resistance. The treatment is delayed and is not satisfactory. As the present drugs are not effective enough against the resistant bacteria, viruses, and other microbial agents, there is a need to look for and find newer drugs. Usage of antibiotics when limited could avoid the spread of opposition in the microbial network. In this way, reasonable utilization of antimicrobial agents and the quest for newer antimicrobial agents have a high significance and impact on the future generation. This review article aims to highlight the burden of AMR in the world and discuss the mechanism; possible risks involved in the treatment of microbial infections in future generations and also about the steps to be taken to prevent the complications of AMR. Impact of AMR can only be prevented by taking timely appropriate actions such as judicial use of antimicrobial agents both for the treatment of human beings and in other fields such as veterinary, poultry, and agriculture. Unless this huge step is taken, it will be impossible to cope with the burden and impact of AMR.
- Publication
Drug Invention Today, 2019, Vol 12, Issue 11, p2769
- ISSN
0975-7619
- Publication type
Article